Crexendo director granted 10,000 stock options
Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, all held as direct ownership. The options vest over 36 equal monthly installments beginning on April 4, 2026, meaning the right to exercise builds gradually over three years rather than all at once.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 10,000 | $6.47 | $65K |
Footnotes (1)
- F1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Crexendo (CXDO) director Chris McKee report?
What are the key terms of Chris McKee’s Crexendo (CXDO) option grant?
Is Chris McKee’s Crexendo (CXDO) option grant a buy or sell transaction?
How many Crexendo (CXDO) options does Chris McKee hold after this transaction?
How do the Crexendo (CXDO) options granted to Chris McKee vest over time?
AI-generated analysis. How Rhea-AI works. Not financial advice.